Inge L. Huibregtse - Concepedia

Author

Inge L. Huibregtse

Also Known As

I Huibregtse, I L Huibregtse, I. Huibregtse, I. L. Huibregtse, I.L. Huibregtse, Inge Huibregtse, Inge L Huibregtse, Inge L. Huibregtse, Inge Louise Huibregtse, Karin Horsthuis

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

The Netherlands Cancer Institute Amsterdam UMC Location University of Amsterdam University of Amsterdam Leiden University Medical Center Spaarne Gasthuis

About

Inge L. Huibregtse is an author at The Netherlands Cancer Institute specializing in medicine, immunology, and surgery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	397
2	Health Sciences	2	2	121
3	Allergy	1	1	85
4	Cell Biology	1	1	67
5	Diabetes	1	1	85

Inge L. Huibregtse

Publications

963

Citations

H-Index

Page 1

	Year	Citations
Neoadjuvant Immunotherapy in Locally Advanced Mismatch Repair–Deficient Colon Cancer Myriam Chalabi, Y.L. Verschoor, Pedro Batista Tan, New England Journal of Medicine	2024	305
Induction of Ovalbumin-Specific Tolerance by Oral Administration of Lactococcus lactis Secreting Ovalbumin Inge L. Huibregtse, Veerle Snoeck, An De Creus, Gastroenterology ProbioticHealth SciencesMedicineKlebsiella PneumoniaeOral Administration	2007	106
Long-term Quality of Life and Functional Outcome of Patients With Rectal Cancer Following a Watch-and-Wait Approach Petra A. Custers, Marit E. van der Sande, Brechtje A. Grotenhuis, JAMA Surgery	2023	106
Neoadjuvant nivolumab, ipilimumab, and celecoxib in MMR-proficient and MMR-deficient colon cancers: Final clinical analysis of the NICHE study. Y.L. Verschoor, José van den Berg, Geerard L. Beets, Journal of Clinical Oncology Surgical OncologyImmunologyPathologyImmunotherapyOncology	2022	92
Induction of Antigen-Specific Tolerance by Oral Administration of <i>Lactococcus lactis</i> Delivered Immunodominant DQ8-Restricted Gliadin Peptide in Sensitized Nonobese Diabetic Ab° Dq8 Transgenic Mice Inge L. Huibregtse, Eric Marietta, Shadi Rashtak, The Journal of Immunology Immune ToleranceImmunologyImmune RegulationImmunodominancePathology	2009	85
Physical Interaction between GATA-5 and Hepatocyte Nuclear Factor-1α Results in Synergistic Activation of the Human Lactase-Phlorizin Hydrolase Promoter Herbert M. van Wering, Inge L. Huibregtse, Sanne M. van der Zwan, Journal of Biological Chemistry	2002	80
In Vitro and In Vivo Down-Regulation of Regulatory T Cell Activity with a Peptide Inhibitor of TGF-β1 Lucía Gil‐Guerrero, Javier Dotor, Inge L. Huibregtse, The Journal of Immunology T-regulatory CellImmune RegulationImmunologyRegulatory T CellsImmunologic Mechanism	2008	67
A prospective randomized trial of Tannenbaum-type Teflon-coated stents versus polyethylene stents for distal malignant biliary obstruction Anne‐Marie van Berkel, Inge L. Huibregtse, Jacques Bergman, European Journal of Gastroenterology & Hepatology	2004	36
Prevention of experimental colitis by parenteral administration of a pathogen-derived immunomodulatory molecule Henri Braat, Peter McGuirk, F.J.W. ten Kate, Gut	2006	27
Upper endoscopy after Roux-en-Y gastric bypass: diagnostic yield and factors associated with relevant findings Thomas C. C. Boerlage, Paula J. D. Wolvers, Sjoerd C. Bruin, Surgery for Obesity and Related Diseases Roux-en-y Gastric BypassMedicineGastroenterologyGastric BypassSurgery	2020	17

Page 1